New cocktail of drugs and supplements targets Hard-to-Treat pancreatic cancer

NCT ID NCT02336087

First seen Feb 04, 2026 · Last updated Apr 30, 2026 · Updated 12 times

Summary

This early-phase study is testing a mix of two chemotherapy drugs (gemcitabine and Abraxane), a diabetes drug (metformin), and a special dietary supplement in people with pancreatic cancer that cannot be removed by surgery. The main goal is to see if this combination is safe and feasible for patients. The supplement includes ingredients like curcumin, vitamins, and plant extracts that may help slow cancer growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

  • City of Hope Rancho Cucamonga

    Rancho Cucamonga, California, 91730, United States

  • City of Hope South Pasadena

    South Pasadena, California, 91030, United States

  • City of Hope West Covina

    West Covina, California, 91790, United States

Conditions

Explore the condition pages connected to this study.